ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $73,065,000 | -11.2% | 4,806,900 | -1.9% | 0.88% | -10.3% |
| Q2 2018 | $82,237,000 | +2.8% | 4,900,900 | 0.0% | 0.98% | -1.1% |
| Q1 2018 | $79,983,000 | -18.0% | 4,900,900 | -35.7% | 0.99% | -19.6% |
| Q4 2017 | $97,554,000 | -44.1% | 7,621,400 | -46.3% | 1.23% | -26.0% |
| Q3 2017 | $174,450,000 | +47.0% | 14,182,900 | 0.0% | 1.67% | +34.0% |
| Q2 2017 | $118,711,000 | -6.4% | 14,182,900 | 0.0% | 1.24% | -13.4% |
| Q1 2017 | $126,795,000 | -10.3% | 14,182,900 | -11.8% | 1.44% | -20.3% |
| Q4 2016 | $141,421,000 | +47.8% | 16,088,800 | +13.5% | 1.80% | +65.3% |
| Q3 2016 | $95,714,000 | +145.0% | 14,179,900 | +29.2% | 1.09% | +167.2% |
| Q2 2016 | $39,067,000 | +23.9% | 10,973,900 | +2.7% | 0.41% | +22.9% |
| Q1 2016 | $31,533,000 | -30.1% | 10,689,000 | 0.0% | 0.33% | -18.6% |
| Q4 2015 | $45,108,000 | -1.7% | 10,689,000 | +6.2% | 0.41% | -11.9% |
| Q3 2015 | $45,876,000 | -39.7% | 10,060,500 | -4.7% | 0.46% | -17.0% |
| Q2 2015 | $76,141,000 | -0.0% | 10,560,500 | +2.2% | 0.56% | -14.2% |
| Q1 2015 | $76,149,000 | +122.1% | 10,332,310 | +42.6% | 0.65% | +98.2% |
| Q4 2014 | $34,282,000 | +50.0% | 7,247,700 | +13.2% | 0.33% | +37.2% |
| Q3 2014 | $22,858,000 | -21.7% | 6,402,800 | 0.0% | 0.24% | -30.3% |
| Q2 2014 | $29,197,000 | -1.3% | 6,402,800 | +1.7% | 0.34% | -5.8% |
| Q1 2014 | $29,596,000 | +10.9% | 6,297,000 | +18.3% | 0.36% | -7.1% |
| Q4 2013 | $26,678,000 | -11.2% | 5,325,000 | +10.2% | 0.39% | -26.9% |
| Q3 2013 | $30,053,000 | +36.1% | 4,831,600 | -0.7% | 0.54% | +14.5% |
| Q2 2013 | $22,087,000 | – | 4,865,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|